In contrast, another US retrospective analysis of 31 lymphoma patients relapsed after allo-HSCT receiving PD-1 blockade revealed a high frequency of GVHD (17/31 patients) and 8 patients died due to GVHD [78]. This evidence concerns the gene PDCD1 and graft versus host disease.